- Home
- OHI vs QGEN Comparison
OHI vs QGEN Comparison
Compare OHI & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OHI
- QGEN
- Stock Information
- Founded
- OHI N/A
- QGEN 1986
- Country
- OHI United States
- QGEN Netherlands
- Employees
- OHI N/A
- QGEN N/A
- Industry
- OHI Real Estate Investment Trusts
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OHI Real Estate
- QGEN Health Care
- Exchange
- OHI Nasdaq
- QGEN Nasdaq
- Market Cap
- OHI 10.8B
- QGEN 9.1B
- IPO Year
- OHI N/A
- QGEN 1996
- Fundamental
- Price
- OHI $36.95
- QGEN $46.76
- Analyst Decision
- OHI Buy
- QGEN Buy
- Analyst Count
- OHI 9
- QGEN 7
- Target Price
- OHI $40.88
- QGEN $49.51
- AVG Volume (30 Days)
- OHI 2.5M
- QGEN 1.4M
- Earning Date
- OHI 07-31-2025
- QGEN 07-30-2025
- Dividend Yield
- OHI 7.25%
- QGEN 2.83%
- EPS Growth
- OHI 44.22
- QGEN N/A
- EPS
- OHI 1.60
- QGEN 0.42
- Revenue
- OHI $1,084,876,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- OHI $12.23
- QGEN $6.36
- Revenue Next Year
- OHI $5.93
- QGEN $6.18
- P/E Ratio
- OHI $23.10
- QGEN $110.70
- Revenue Growth
- OHI 11.29
- QGEN 3.31
- 52 Week Low
- OHI $32.48
- QGEN $37.63
- 52 Week High
- OHI $44.42
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- OHI 50.35
- QGEN 64.44
- Support Level
- OHI $35.89
- QGEN $46.25
- Resistance Level
- OHI $37.29
- QGEN $47.70
- Average True Range (ATR)
- OHI 0.69
- QGEN 0.62
- MACD
- OHI 0.00
- QGEN -0.00
- Stochastic Oscillator
- OHI 54.08
- QGEN 68.56
About OHI Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).